Corrigendum: PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors (PPAR Research (2010) 2010 (427401) DOI: 10.1155/2010/427401);PPARs in human neuroepithelial tumors: PPAR ligands as anticancer therapies for the most common human neuroepithelial tumors

PPAR Research

Volumn 2019, Issue , 2010, Pages

  Cimini, Annamaria ^a   Benedetti, Elisabetta ^a   Galzio, Renato ^a   D'Angelo, Barbara ^a   Cer, Maria Paola ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FIBRIC ACID DERIVATIVE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE;

ASTROCYTOMA; BRAIN; CANCER CHEMOTHERAPY; CANCER THERAPY; CARDIOVASCULAR DISEASE; GLIOBLASTOMA; GLIOMA; HUMAN; HYPERTRIGLYCERIDEMIA; NEUROBLASTOMA; NEUROEPITHELIOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PILOCYTIC ASTROCYTOMA; PLEOMORPHIC XANTHOASTROCYTOMA; PROTEIN EXPRESSION; REVIEW; SUBEPENDYMAL GIANT CELL ASTROCYTOMA;

EID: 77951577106     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2019/4309068     Document Type: Erratum

References (110)

1. Cavenee W. K., Furnari F. B., Nagane M., Kleihues P., Cavenee W. K., Diffusely infiltrating astrocytomas Pathology and Genetics of Tumours of the Nervous System 2000 Lyon, France International Agency for Research on Cancer 10 21
2. Burger P. C., Scheithauer B. W., Paulus W., Kleihues P., Cavenee W. K., Pilocytic astrocytoma Pathology and Genetics of Tumours of the Nervous System 2000 Lyon, France International Agency for Research on Cancer 45 51
3. Kleihues P., Davis R. L., Ohgaki H., Kleihues P., Cavenee W. K., Diffuse astrocytoma Pathology and Genetics of Tumours of the Nervous System 2000 Lyon, France International Agency for Research on Cancer 22 26
4. Kitange G. J., Templeton K. L., Jenkins R. B., Recent advances in the molecular genetics of primary gliomas Current Opinion in Oncology 2003 15 3 197 203 (Pubitemid 36735172)
5. Kleihues P., Davis R. L., Coons S. W., Kleihues P., Cavenee W. K., Anaplastic astrocytoma Pathology and Genetics of Tumours of the Nervous System 2000 Lyon, France International Agency for Research on Cancer 27 28
6. Kleihues P., Burger P. C., Collins V. P., Kleihues P., Cavenee W. K., Glioblastoma Pathology and Genetics of Tumours of the Nervous System 2000 Lyon, France International Agency for Research on Cancer 29 39
7. Gurney J. G., Kadan-Lottick N., Brain and other central nervous system tumors: rates, trends, and epidemiology Current Opinion in Oncology 2001 13 3 160 166 (Pubitemid 32433971)
8. Jiang H., Conrad C., Fueyo J., Gomez-Manzano C., Liu T. J., Oncolytic adenoviruses for malignant glioma therapy Frontiers in Bioscience 2003 8 d577 d588 (Pubitemid 38943211)
9. Fan X., Aalto Y., Sanko S. G., Knuutila S., Klatzmann D., Castresana J. S., Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas International Journal of Oncology 2002 21 5 1141 1150
10. Ishii N., Maier D., Merlo A., Frequent co-alteration of TP53, p16/CDKN 2S, p14ARF, PTEN tumor suppressor genes in human glioblastoma cell lines Brain Pathology 1999 9 469 479 (Pubitemid 29316287)
11. Kleihues P., Cavenee W. K., Pathology and Genetics of Tumours of the Nervous System 2000 Lyon, France International Agency for Research on Cancer
12. Kleihues P., Louis D. N., Scheithauer B. W., The WHO classification of tumors of the nervous system Journal of Neuropathology and Experimental Neurology 2002 61 3 215 225 (Pubitemid 34212595)
13. Reardon D. A., Rich J. N., Friedman H. S., Bigner D. D., Recent advances in the treatment of malignant astrocytoma Journal of Clinical Oncology 2006 24 8 1253 1265 (Pubitemid 46622028)
14. Brodeur G. M., Seeger R. C., Schwab M., Varmus H. E., Bishop J. M., Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage Science 1984 224 4653 1121 1124 (Pubitemid 14106392)
15. National Cancer Institute, Surveillance, Epidemiology and End Results Database. November, 2005, http://seer.cancer.gov/
16. Schwab M., Tonini G. P., Benard J., Human Neuroblastoma. Recent Advances in Clinical and Genetic Analysis 1993 Chur, Switzerland Harwood Academic Publishers
17. Seeger R. C., Brodeur G. M., Sather H., Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas The New England Journal of Medicine 1985 313 18 1111 1116 (Pubitemid 16216827)
18. White P. S., Thompson P. M., Seifried B. A., Detailed molecular analysis of 1p36 in neuroblastoma Medical and Pediatric Oncology 2001 36 1 37 41
19. White P. S., Thompson P. M., Gotoh T., Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma Oncogene 2005 24 16 2684 2694 (Pubitemid 40593096)
20. Sidell N., Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro Journal of the National Cancer Institute 1982 68 4 589 596 (Pubitemid 12078843)
21. Biedler J. L., Helson L., Spengler B. A., Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture Cancer Research 1973 33 11 2643 2652
22. Pahlman S., Odelstad L., Larsson E., Grotte G., Nilsson K., Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl- phorbol-13-acetate International Journal of Cancer 1981 28 5 583 589 (Pubitemid 11030489)
23. Parrow V., Nanberg E., Heikkila J., Hammerling U., Pahlman S., Protein kinase C remains functionally active during TPA induced neuronal differentiation of SH-SY5Y human neuroblastoma cells Journal of Cellular Physiology 1992 152 3 536 544
24. Fagerstrm S., Phlman S., Gestblom C., Nnberg E., Protein kinase C- is implicated in neurite outgrowth in differentiating human neuroblastoma cells Cell Growth and Differentiation 1996 7 6 775 785 (Pubitemid 26360746)
25. van Wijk J., Coll B., Cabezas M. C., Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients Clinical and Experimental Pharmacology and Physiology 2006 33 12 1134 1137 (Pubitemid 44923898)
26. Linz W., Wohlfart P., Baader M., The peroxisome proliferator-activated receptor- (PPAR- ) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats Acta Pharmacologica Sinica 2009 30 7 935 946
27. Galli A., Mello T., Ceni E., Surrenti E., Surrenti C., The potential of antidiabetic thiazolidinediones for anticancer therapy Expert Opinion on Investigational Drugs 2006 15 9 1039 1049 (Pubitemid 44314656)
28. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650 (Pubitemid 20356241)
29. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W., Control of the peroxisomal -oxidation pathway by a novel family of nuclear hormone receptors Cell 1992 68 5 879 887
30. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions Progress in Lipid Research 2006 45 2 120 159 (Pubitemid 43248732)
31. Nolte R. T., Wisely G. B., Westin S., Ligand binding and co-activator assembly of the peroxisome proliferator- activated receptor- Nature 1998 395 6698 137 143 (Pubitemid 28425645)
32. Kersten S., Wahli W., Peroxisome proliferator activated receptor agonists EXS 2000 89 141 151
33. Willson T. M., Brown P. J., Sternbach D. D., Henke B. R., The PPARs: from orphan receptors to drug discovery Journal of Medicinal Chemistry 2000 43 4 527 550
34. Vanden Heuvel J. P., Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis Journal of Nutrition 1999 129 supplement 2 575S 580S
35. Cimini A., Cristiano L., Bernardo A., Farioli-Vecchioli S., Stefanini S., Cer M. P., Presence and inducibility of peroxisomes in a human glioblastoma cell line Biochimica et Biophysica Acta 2000 1474 3 397 409 (Pubitemid 30209882)
36. Heneka M. T., Landreth G. E., PPARs in the brain Biochimica et Biophysica Acta 2007 1771 8 1031 1045
37. Barak Y., Sadovsky Y., Shalom-Barak T., PPAR signaling in placental development and function PPAR Research 2008 2008 11 (Pubitemid 350243188)
38. Escher P., Wahli W., Peroxisome proliferator-activated receptors: insight into multiple cellular functions Mutation Research 2000 448 2 121 138 (Pubitemid 30139449)
39. Keller J. M., Collet P., Bianchi A., Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease International Journal of Developmental Biology 2000 44 5 429 442
40. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., Desvergne B., Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding Endocrinology 2001 142 10 4195 4202 (Pubitemid 32907045)
41. Shi Y., Hon M., Evans R. M., The peroxisome proliferator-activated receptor, an integrator of transcriptional repression and nuclear receptor signaling Proceedings of the National Academy of Sciences of the United States of America 2002 99 5 2613 2618 (Pubitemid 34240509)
42. Bastie C., PPAR and PPAR : roles in fatty acids signalling, implication in tumorigenesis Bulletin du Cancer 2002 89 1 23 28 (Pubitemid 34151312)
43. Michalik L., Desvergne B., Wahli W., Peroxisome proliferator-activated receptors / : emerging roles for a previously neglected third family member Current Opinion in Lipidology 2003 14 2 129 135 (Pubitemid 36521182)
44. Lemberger T., Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology Annual Review of Cell and Developmental Biology 1996 12 335 363 (Pubitemid 26422717)
45. Berger J., Moller D. E., The mechanisms of action of PPARs Annual Review of Medicine 2002 53 409 435 (Pubitemid 34177889)
46. Hostetler H. A., Petrescu A. D., Kier A. B., Schroeder F., Peroxisome proliferator-activated receptor interacts with high affinity and is conformationally responsive to endogenous ligands The Journal of Biological Chemistry 2005 280 19 18667 18682 (Pubitemid 41379567)
47. Schopfer F. J., Lin Y., Baker P. R. S., Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor ligand Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2340 2345 (Pubitemid 40279377)
48. Shiraki T., Kamiya N., Shiki S., Kodama T. S., Kakizuka A., Jingami H., -unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor The Journal of Biological Chemistry 2005 280 14 14145 14153 (Pubitemid 40517317)
49. Tan N.-S., Shaw N. S., Vinckenbosch N., Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription Molecular and Cellular Biology 2002 22 14 5114 5127 (Pubitemid 34700702)
50. Grommes C., Landreth G. E., Heneka M. T., Antineoplastic effects of peroxisome proliferator-activated receptor agonists Lancet Oncology 2004 5 7 419 429 (Pubitemid 38878045)
51. Tontonoz P., Singer S., Forman B. M., Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor and the retinoid X receptor Proceedings of the National Academy of Sciences of the United States of America 1997 94 1 237 241 (Pubitemid 27027193)
52. Elstner E., Mller C., Koshizuka K., Ligands for peroxisome proliferator-activated receptor and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice Proceedings of the National Academy of Sciences of the United States of America 1998 95 15 8806 8811 (Pubitemid 28350570)
53. Mueller E., Sarraf P., Tontonoz P., Terminal Differentiation of Human Breast Cancer through PPAR Molecular Cell 1998 1 3 465 470 (Pubitemid 128378895)
54. Kubota T., Koshizuka K., Williamson E. A., Ligand for peroxisome proliferator-activated receptor (Troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo Cancer Research 1998 58 15 3344 3352 (Pubitemid 28371075)
55. Brockman J. A., Gupta R. A., Dubois R. N., Activation of PPAR leads to inhibition of anchorage-independent growth of human colorectal cancer cells Gastroenterology 1998 115 5 1049 1055
56. Sarraf P., Mueller E., Jones D., Differentiation and reversal of malignant changes in colon cancer through PPAR Nature Medicine 1998 4 9 1046 1052 (Pubitemid 28417337)
57. Chang T.-H., Szabo E., Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor in non-small cell lung cancer Cancer Research 2000 60 4 1129 1138 (Pubitemid 30129556)
58. Motomura W., Okumura T., Takahashi N., Obara T., Kohgo Y., Activation of peroxisome proliferator-activated receptor by troglitazone inhibits cell growth through the increase of p27(Kip1) in human pancreatic carcinoma cells Cancer Research 2000 60 19 5558 5564
59. Guan Y.-F., Zhang Y.-H., Breyer R. M., Davis L., Breyer M. D., Expression of peroxisome proliferator-activated receptor (PPAR ) in human transitional bladder cancer and its role in inducing cell death Neoplasia 1999 1 4 330 339
60. Sato H., Ishihara S., Kawashima K., Expression of peroxisome proliferator-activated receptor (PPAR) in gastric cancer and inhibitory effects of PPAR agonists British Journal of Cancer 2000 83 10 1394 1400
61. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-,-, and- in the adult rat Endocrinology 1996 137 1 354 366 (Pubitemid 26005011)
62. Basu-Modak S., Braissant O., Escher P., Desvergne B., Honegger P., Wahli W., Peroxisome proliferator-activated receptor regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures The Journal of Biological Chemistry 1999 274 50 35881 35888 (Pubitemid 129512894)
63. Marszalek J. R., Kitidis C., Dararutana A., Lodish H. F., Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth The Journal of Biological Chemistry 2004 279 23 23882 23891 (Pubitemid 38725245)
64. Peters J. M., Lee S. S. T., Li W., Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor () Molecular and Cellular Biology 2000 20 14 5119 5128 (Pubitemid 30431565)
65. Michalik L., Desvergne B., Dreyer C., Gavillet M., Laurini R. N., Wahli W., PPAR expression and function during vertebrate development International Journal of Developmental Biology 2002 46 1 105 114 (Pubitemid 34226309)
66. Cimini A., Benedetti E., Cristiano L., Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons Neuroscience 2005 130 2 325 337 (Pubitemid 40125471)
67. Woods J. W., Tanen M., Figueroa D. J., Localization of PPAR in murine central nervous system: expression in oligodendrocytes and neurons Brain Research 2003 975 1-2 10 21 (Pubitemid 36588548)
68. Moreno S., Farioli-vecchioli S., Cer M. P., Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 2004 123 1 131 145 (Pubitemid 37518482)
69. Benani A., Krmarik-Bouillaud P., Bianchi A., Netter P., Minn A., Daua M., Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord Journal of Chemical Neuroanatomy 2003 25 1 29 38 (Pubitemid 36164853)
70. Granneman J., Skoff R., Yang X., Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes Journal of Neuroscience Research 1998 51 5 563 573 (Pubitemid 28115057)
71. Saluja I., Granneman J. G., Skoff R. P., PPAR agonists stimulate oligodendrocyte differentiation in tissue culture Glia 2001 33 3 191 204 (Pubitemid 32219128)
72. Bernardo A., Ajmone-Cat M. A., Levi G., Minghetti L., 15-deoxy- 12,14 -prostaglandin J 2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms Journal of Neurochemistry 2003 87 3 742 751 (Pubitemid 37310639)
73. Cullingford T. E., Bhakoo K., Peuchen S., Dolphin C. T., Patel R., Clark J. B., Distribution of mRNAs encoding the peroxisome proliferator-activated receptor, and and the retinoid X receptor, and in rat central nervous system Journal of Neurochemistry 1998 70 4 1366 1375
74. Cristiano L., Bernardo A., Cer M. P., Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes Journal of Neurocytology 2001 30 8 671 683 (Pubitemid 33816127)
75. Cristiano L., Cimini A., Moreno S., Ragnelli A. M., Cer M. P., Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures Neuroscience 2005 131 3 577 587 (Pubitemid 40261214)
76. Cimini A., Cristiano L., Benedetti E., DAngelo B., Cer M. P., PPARs expression in adult mouse neural stem cells: modulation of PPARs during astroglial differentiaton of NSC PPAR Research 2007 2007 10 (Pubitemid 47075763)
77. Cimini A., Cer M. P., Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation Stem Cell Reviews 2008 4 4 293 303
78. Farioli-Vecchioli S., Moreno S., Cer M. P., Immunocytochemical localization of acyl-CoA oxidase in the rat central nervous system Journal of Neurocytology 2001 30 1 21 33 (Pubitemid 33078956)
79. Heneka M. T., Klockgether T., Feinstein D. L., Peroxisome proliferator-activated receptor- ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo Journal of Neuroscience 2000 20 18 6862 6867
80. Braissant O., Wahli W., Differential expression of peroxisome proliferator-activated receptor-,-, and- during rat embryonic development Endocrinology 1998 139 6 2748 2754 (Pubitemid 28512383)
81. Cimini A., Benedetti E., Cristiano L., Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons Neuroscience 2005 130 2 325 337 (Pubitemid 40125471)
82. Grommes C., Landreth G. E., Schlegel U., Heneka M. T., The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells Journal of Pharmacology and Experimental Therapeutics 2005 313 2 806 813 (Pubitemid 40604182)
83. Zander T., Kraus J. A., Grommes C., Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPAR Journal of Neurochemistry 2002 81 5 1052 1060 (Pubitemid 34809288)
84. Prez-Ortiz J. M., Tranque P., Vaquero C. F., Glitazones differentially regulate primary astrocyte and glioma cell survival: involvement of reactive oxygen species and peroxisome proliferator-activated receptor- The Journal of Biological Chemistry 2004 279 10 8976 8985 (Pubitemid 38295959)
85. Berge K., Tronstad K. J., Flindt E. N., Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways Carcinogenesis 2001 22 11 1747 1755 (Pubitemid 33064838)
86. Grommes C., Landreth G. E., Sastre M., Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor agonist treatment Molecular Pharmacology 2006 70 5 1524 1533
87. Chattopadhyay N., Singh D. P., Heese O., Expression of peroxisome proliferator-activated receptors (PPARs) in human astrocytic cells: PPAR agonists as inducers of apoptosis Journal of Neuroscience Research 2000 61 1 67 74 (Pubitemid 30436476)
88. Morosetti R., Servidei T., Mirabella M., The PPAR ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines International Journal of Oncology 2004 25 2 493 502
89. Cimini A., Cristiano L., Colafarina S., PPAR -dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF) International Journal of Cancer 2005 117 6 923 933 (Pubitemid 41688566)
90. Spagnolo A., Grant E. N., Glick R., Lichtor T., Feinstein D. L., Differential effects of PPAR agonists on the metabolic properties of gliomas and astrocytes Neuroscience Letters 2007 417 1 72 77 (Pubitemid 46517843)
91. Benedetti E., Galzio R., Cinque B., Biomolecular characterization of human glioblastoma cells in primary cultures: differentiating and antiangiogenic effects of natural and synthetic PPAR agonists Journal of Cellular Physiology 2008 217 1 93 102
92. Strakova N., Ehrmann J., Bartos J., Malikova J., Dolezel J., Kolar Z., Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors Neoplasma 2005 52 2 126 136 (Pubitemid 40503415)
93. Coras R., Hlsken A., Seufert S., The peroxisome proliferator-activated receptor- agonist troglitazone inhibits transforming growth factor- -mediated glioma cell migration and brain invasion Molecular Cancer Therapeutics 2007 6 6 1745 1754 (Pubitemid 46954051)
94. Yamada N., Kato M., Yamashita H., Enhanced expression of transforming growth factor- and its type-I and type-II receptors in human glioblastoma International Journal of Cancer 1995 62 4 386 392
95. Kawataki T., Naganuma H., Sasaki A., Yoshikawa H., Tasaka K., Nukui H., Correlation of thrombospondin-1 and transforming growth factor- expression with malignancy of glioma Neuropathology 2000 20 3 161 169 (Pubitemid 32963612)
96. Walczak H., Miller R. E., Ariail K., Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nature Medicine 1999 5 2 157 163 (Pubitemid 29068521)
97. Ashkenazi A., Pai R. C., Fong S., Safety and antitumor activity of recombinant soluble Apo2 ligand Journal of Clinical Investigation 1999 104 2 155 162
98. Schultze K., Bck B., Eckert A., Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin Apoptosis 2006 11 9 1503 1512 (Pubitemid 44253668)
99. Benedetti E., Galzio R., Laurenti G., Lipid metabolism impairment in human gliomas: expression of peroxisomal proteins in human gliomas at different grades of malignancy. International Journal of Immunopathology and Pharmacology. In press
100. Servidei T., Morosetti R., Ferlini C., The cellular response to PPAR ligands is related to the phenotype of neuroblastoma cell lines Oncology Research 2004 14 7-8 345 354 (Pubitemid 39070675)
101. Isaac A. O., Kawikova I., Bothwell A. L. M., Daniels C. K., Lai J. C. K., Manganese treatment modulates the expression of peroxisome proliferator- activated receptors in astrocytoma and neuroblastoma cells Neurochemical Research 2006 31 11 1305 1316 (Pubitemid 44800582)
102. Falone S., Grossi M. R., Cinque B., Fifty hertz extremely low-frequency electromagnetic field causes changes in redox and differentiative status in neuroblastoma cells International Journal of Biochemistry and Cell Biology 2007 39 11 2093 2106 (Pubitemid 47369242)
103. Rodway H. A., Hunt A. N., Kohler J. A., Postle A. D., Lillycrop K. A., Lysophosphatidic acid attenuates the cytotoxic and degree of peroxisome proliferator-activated receptor activation induced by 15-deoxy 12,14 -prostaglandin J 2 in neuroblastoma cells Biochemical Journal 2004 382 1 83 91
104. Han S. W., Greene M. E., Pitts J., Wada R. K., Sidell N., Novel expression and function of peroxisome proliferator-activated receptor (PPAR ) in human neuroblastoma cells Clinical Cancer Research 2001 7 1 98 104 (Pubitemid 32110211)
105. Giri S., Rattan R., Singh A. K., Singh I., The 15-deoxy- 12,14-prostaglandin J 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-akt-NF- B-p300 pathway independent of peroxisome proliferator-activated receptor Journal of Immunology 2004 173 8 5196 5208 (Pubitemid 39387803)
106. Emmans V. C., Rodway H. A., Hunt A. N., Lillycrop K. A., Regulation of cellular processes by PPAR ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression Biochemical Society Transactions 2004 32 5 840 842
107. Rossi A., Kapahi P., Natoli G., Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I B kinase Nature 2000 403 6765 103 108 (Pubitemid 30038530)
108. Valentiner U., Carlsson M., Erttmann R., Hildebrandt H., Schumacher U., Ligands for the peroxisome proliferator-activated receptor- have inhibitory effects on growth of human neuroblastoma cells in vitro Toxicology 2005 213 1-2 157 168 (Pubitemid 41191291)
109. Cellai I., Benvenuti S., Luciani P., Antineoplastic effects of rosiglitazone and PPAR transactivation in neuroblastoma cells British Journal of Cancer 2006 95 7 879 888 (Pubitemid 44498104)
110. Di Loreto S., DAngelo B., DAmico M. A., PPAR agonists trigger neuronal differentiation in the human neuroblastoma cell line SH-SY5Y Journal of Cellular Physiology 2007 211 3 837 847 (Pubitemid 46683051)